StockSelector.com
  Research, Select, & Monitor Sunday, April 22, 2018 4:33:04 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Valeant Pharmaceuticals International, Inc.$17.18($.15)(.87%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Valeant Pharmaceuticals International, Inc. has an overall rank of 1156 out of 6819 stocks based on 14 positive rankings and 11 negative rankings.

Positive Rankings
Top Industry Values
Valeant Pharmaceuticals International rank is 32
Top Intrinsic Values
Valeant Pharmaceuticals International rank is 32
PEGValue
Valeant Pharmaceuticals International has a PEG Value of $67.75. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 294.36% in the next year. Among companies with a PEG Value above the current stock price, Valeant Pharmaceuticals International is ranked 123.
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Valeant Pharmaceuticals International is ranked 197.
Highest ROE
Valeant Pharmaceuticals International rank is 209
Highest Net Margin
Valeant Pharmaceuticals International rank is 410
10 Day Gain
Valeant Pharmaceuticals International rank is 516
Low vPut/Call
Valeant Pharmaceuticals International has a low Put/Call ratio of 0.29 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Valeant Pharmaceuticals International is ranked 542.
Historic Revenue Growth
Valeant Pharmaceuticals International rank is 676
Price-to-Book
Valeant Pharmaceuticals International rank is 753
Price-to-Sales
Valeant Pharmaceuticals International rank is 858
SSValue
The StockSelector Value for Valeant Pharmaceuticals International is $23.44. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Valeant Pharmaceuticals International is ranked 973.
Highest ROA
Valeant Pharmaceuticals International rank is 1030
Estimated EPS Growth
Valeant Pharmaceuticals International rank is 1403
Negative Rankings
Down EPS Surprise
Valeant Pharmaceuticals International missed the consensus earnings estimate when it last reported quarterly earnings.
Negative Stoch Cross
Valeant Pharmaceuticals International rank is 48
Negative Guidance
Within the past 90 days Valeant Pharmaceuticals International has provided guidance belwo the consensus estimates. Statistics show companies that provide negative guidance underperform the market in the short-term.
Missed Whisper
According to EarningsWhispers.com, Valeant Pharmaceuticals International missed the Earnings Whisper number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper number underperform the market in the short-term.
Negative Revenue Estimate
Valeant Pharmaceuticals International rank is 228
High Put/Call
Valeant Pharmaceuticals International has a high Put/Call ratio of 1.77 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Valeant Pharmaceuticals International is ranked 320.
Down Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have decreased by a combined (.15%). Among companies that have had their estimates lowerec within the past month, Valeant Pharmaceuticals International is ranked 656.
Debt-to-Equity
Valeant Pharmaceuticals International rank is 753
90 Day Loss
Valeant Pharmaceuticals International rank is 915
Negative Past Growth
Valeant Pharmaceuticals International rank is 915
Negative Cash Growth
Valeant Pharmaceuticals International rank is 1394







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.